FDA to import more of cancer drug from China

The US is plan­ning to im­port more dos­es of the chemother­a­py cis­platin that is still in short sup­ply.

A spokesper­son for Apo­tex, a gener­ic med­i­cine com­pa­ny that is dis­trib­ut­ing the Chi­nese-made drug in the US, said that the com­pa­ny is ex­pect­ing 10 more batch­es of a ver­sion of cis­platin man­u­fac­tured by Qilu Phar­ma­ceu­ti­cal, which will ar­rive for dis­tri­b­u­tion from Chi­na lat­er this week.

“We will con­tin­ue to work with the FDA and our part­ner as long as the need re­mains to help en­sure an un­in­ter­rupt­ed sup­ply of these crit­i­cal med­i­cines,” an Apo­tex spokesper­son told End­points News. 

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN